Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis: Protocol for a Pragmatic Cluster Randomized Clinical Trial (PREDICT-AMY)

NCT05557162 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05557162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05557162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis: Protocol for a Pragmatic Cluster Randomized Clinical Trial (PREDICT-AMY)
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
June 19, 2023
Completion date
July 23, 2025
Enrollment
20,143 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac amyloidosis